To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program.
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™This bill, H.R. 4881 from the 118th Congress, proposes an amendment to title XVIII of the Social Security Act to limit cost sharing for prescription drugs under the Medicare program. The goal is to reduce out-of-pocket expenses for Medicare beneficiaries when obtaining medications. The bill was referred to the House Subcommittee on Health but ultimately failed or expired without further legislative action. No full text or detailed summary is available in the provided data.
H.R. 4881 aimed to reduce Medicare beneficiaries' drug cost sharing but did not advance beyond subcommittee referral and expired.
- The bill seeks to amend the Social Security Act to limit cost sharing for drugs under Medicare.
- It was introduced in the House and referred to the Subcommittee on Health on December 17, 2024.
- The bill did not progress and is currently classified as failed or expired.
['Medicare beneficiaries who pay for prescription drugs', 'Healthcare providers and pharmacies serving Medicare patients', 'Potentially Medicare program administrators managing drug coverage']
['The absence of detailed bill text limits understanding of specific cost-sharing limits or mechanisms.', 'Implementation challenges could arise in adjusting Medicare drug coverage and cost-sharing structures.', 'Potential budgetary impacts on Medicare funding or drug pricing are not detailed.', 'Oversight and enforcement provisions are unknown due to lack of full text.']
The bill was introduced in the House during the 118th Congress and referred to the Subcommittee on Health. It did not advance further and is marked as failed or expired. The policy area is health, specifically Medicare drug cost sharing, which is a recurring topic in congressional health policy discussions.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Potential reduction in out-of-pocket drug costs could increase medication adherence among Medicare beneficiaries.', 'Changes in cost sharing might affect Medicare program expenditures and drug pricing negotiations.', 'Healthcare providers might experience changes in billing or reimbursement processes related to Medicare drug coverage.']
The lack of a bill summary and full text limits transparency and public understanding of the specific provisions and their implications. Tracking the bill's referral and failure status highlights the importance of monitoring legislative progress and availability of detailed legislative documents for informed public oversight.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.